Tag Archives: takes

Pfizer, Merck KGaA's Bavencio takes a hit with second ovarian cancer failure

Back in November, Pfizer and Merck KGaA reported that immuno-oncology drug Bavencio had failed a late-stage ovarian cancer trial. And now the companies can make it two. Friday, the partners said they’d scrapped a phase 3 study examining Bavencio in combination with and/or after chemo in previously untreated patients after the drug showed it couldn’t… Read More »

Seqirus to spend $140M, add 120 jobs at U.S. plant as it takes cell-based flu vaccines global

Seqirus has big plans for its cell-based flu vaccine franchise, and after a scale-up to reach 20 million doses this year, the company still needs more capacity. The vaccine maker has unveiled a $ 140 million expansion to its Holly Springs, North Carolina, manufacturing plant as it aims to take the vaccine global. The expansion… Read More »